New pneumococcal vaccine for routine childhood immunisation

Wyeth has launched Prevenar 13 for active immunisation against invasive disease, pneumonia and acute otitis media caused by Streptococcus pneumoniae.

On 19 January 2010, the Department of Health announced that Prevenar 13 would replace Prevenar in the routine childhood immunisation programme. Prevenar 13 is administered intramuscularly in the same dose schedule as Prevenar, but offers protection against 6 additional strains of S. pneumoniae (1, 3, 5, 6A, 7F and 19A).

Children who have already received 1 or 2 doses of 7-valent Prevenar should complete their vaccination course with Prevenar 13.

European serotype surveillance studies suggest that the new vaccine will protect against 73–100% of the pneumococcal strains that cause invasive disease in children under 5 years old.

View Prevenar 13 drug record

Further information: Wyeth

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases